BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2015 4:43:00 PM | Browse: 1186 | Download: 2166
 |
Received |
|
2014-09-16 16:26 |
|
Peer-Review Started |
|
2014-09-20 14:02 |
|
To Make the First Decision |
|
2014-11-14 19:50 |
|
Return for Revision |
|
2014-12-15 14:37 |
|
Revised |
|
2015-02-27 00:00 |
|
Second Decision |
|
2015-03-09 09:01 |
|
Accepted by Journal Editor-in-Chief |
|
2015-03-09 21:37 |
|
Accepted by Executive Editor-in-Chief |
|
2015-04-02 16:15 |
|
Articles in Press |
|
2015-04-02 16:15 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-05-07 16:07 |
|
Publish the Manuscript Online |
|
2015-05-20 16:43 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Retrospective Study |
| Article Title |
Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kerstin Herzer, Angela Papadopoulos-Köhn, Anne Achterfeld, Ali Canbay, Katja Piras-Straub, Andreas Paul, Andreas Walker, Jörg Timm and Guido Gerken |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Federal funds for the National Reference Centre for Hepatitis C |
|
| Astellas, Biotest and Novartis |
|
|
| Corresponding Author |
Kerstin Herzer, MD, Associate Professor, Department of Gastroenterology and Hepatology, University Hospital Essen, Hufelandstr. 55, 45122 Essen,
Germany. kerstin.herzer@uk-essen.de
|
| Key Words |
Liver transplantation; Telaprevir; Hepatitis C virus recurrence; Predictors; Hepatitis C virus therapy |
| Core Tip |
Experiences with telaprevir-based triple therapy in 19 patients with hepatitis C virus recurrence after liver transplantation are analysed and described in detail. We observed a exceptionally high sustained viral response rate and analyzed clinicopathological factors which might contribute to predict which patients rather benefit from this therapy and which do not. While the new generation directly acting antivirals start to be available in some countries, many parts of the world will not have the privilege of these therapeutic options for a long time. Therefore we are eager to share our experiences with telaprevir in liver transplantation patients with the international hepatologist community.
|
| Publish Date |
2015-05-20 16:43 |
| Citation |
Herzer K, Papadopoulos-Köhn A, Achterfeld A, Canbay A, Piras-Straub K, Paul A, Walker A, Timm J, Gerken C. Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant. World J Hepatol 2015; 7(9): 1287-1296 |
| URL |
http://www.wjgnet.com/1948-5182/full/v7/i9/1287.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v7.i9.1287 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
